Antithrombin iii injection
Products billed under this code include Thrombate III.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Thrombate III.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Thrombate III | Grifols USA, LLC | 13533-0602-50 | 1 | $4.264 |
| Thrombate III | Grifols USA, LLC | 13533-0606-12 | 1 | $4.264 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $4.264 | +$0.09 | 1 IU | Antithrombin iii injection | v1, posted September 17, 2026 |
| 3Q26 | $4.174 | +$0.074 | 1 IU | Antithrombin iii injection | v1, posted September 15, 2026 |
| 2Q26 | $4.10 | +$0.048 | 1 IU | Antithrombin iii injection | v1, posted September 15, 2026 |
| 1Q26 | $4.052 | −$0.052 | 1 IU | Antithrombin iii injection | v1, posted September 15, 2026 |
| 4Q25 | $4.104 | +$0.018 | 1 IU | Antithrombin iii injection | v1, posted September 8, 2026 |
| 3Q25 | $4.086 | +$0.143 | 1 IU | Antithrombin iii injection | v1, posted March 10, 2026 |
| 2Q25 | $3.943 | −$0.018 | 1 IU | Antithrombin iii injection | v1, posted March 10, 2026 |
| 1Q25 | $3.961 | +$0.108 | 1 IU | Antithrombin iii injection | v1, posted December 19, 2025 |
| 4Q24 | $3.853 | −$0.036 | 1 IU | Antithrombin iii injection | v1, posted June 11, 2025 |
| 3Q24 | $3.889 | +$0.152 | 1 IU | Antithrombin iii injection | v1, posted June 11, 2025 |
| 2Q24 | $3.737 | −$0.134 | 1 IU | Antithrombin iii injection | v1, posted March 11, 2025 |
| 1Q24 | $3.871 | +$0.157 | 1 IU | Antithrombin iii injection | v1, posted December 19, 2024 |
| 4Q23 | $3.714 | +$0.364 | 1 IU | Antithrombin iii injection | v1, posted October 10, 2024 |
| 3Q23 | $3.35 | −$0.368 | 1 IU | Antithrombin iii injection | v1, posted June 5, 2024 |
| 2Q23 | $3.718 | +$0.548 | 1 IU | Antithrombin iii injection | v1, posted February 23, 2024 |
| 1Q23 | $3.17 | −$0.329 | 1 IU | Antithrombin iii injection | v1, posted December 6, 2023 |
| 4Q22 | $3.499 | −$0.087 | 1 IU | Antithrombin iii injection | v1, posted June 22, 2023 |
| 3Q22 | $3.586 | +$0.224 | 1 IU | Antithrombin iii injection | v1, posted June 9, 2023 |
| 2Q22 | $3.362 | −$0.188 | 1 IU | Antithrombin iii injection | v1, posted December 14, 2022 |
| 1Q22 | $3.55 | +$0.346 | 1 IU | Antithrombin iii injection | v1, posted June 8, 2022 |
| 4Q21 | $3.204 | −$0.105 | 1 IU | Antithrombin iii injection | v1, posted June 2, 2022 |
| 3Q21 | $3.309 | $0.00 | 1 IU | Antithrombin iii injection | v1, posted June 2, 2022 |
| 2Q21 | $3.309 | −$0.171 | 1 IU | Antithrombin iii injection | v1, posted March 1, 2022 |
| 1Q21 | $3.48 | – | 1 IU | Antithrombin iii injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.